Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Nasopharyngeal Cancer
Illumina to collaborate with Japan's National Cancer Center
By
LabPulse.com staff writers
The study will be part of a trial called the Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing (A-TRAIN). It will include blood samples from up to 96 individuals with nasopharyngeal cancer.
January 23, 2022
Naveris blood test spots recurrence of HPV cancers
By
LabPulse.com staff writers
The test is designed to identify tumor-modified viral HPV DNA. The prospective study, conducted by lead author Dr. Bhisham Chera of the University of North Carolina School of Medicine and colleagues, included 115 patients treated for HPV-related head and neck cancers who were tracked for recurrence for up to 3.5 years with imaging and fiber-optic nasopharyngeal endoscopy. The patients had the blood test before and during treatment and at post-treatment follow-up visits.
February 5, 2020
Page 1 of 1